Sudeep Pharma IPO Opens Tomorrow: Key Details You Should Know

Sudeep Pharma, a well-known company in the speciality chemicals and ingredients segment, is all set to open its initial public offering on Friday, November 21. With strong grey market signals, solid financials, and a growing global footprint, the company’s IPO has already caught the attention of a large number of drawing investors.

 Sudeep Pharma IPO: A Quick Overview

Sudeep Pharma is entering the primary market with a mix of a fresh issue and an offer for sale (OFS), reflecting both its expansion plans and investor exits. Sudeep Pharma, known for manufacturing excipients and specialty ingredients for pharmaceuticals, food, and nutrition industries, enjoys a strong presence across India and key global markets.

The grey market premium (GMP) suggests strong investor appetite ahead of the issue.

ALSO READ | Warren Buffett’s Emotional Farewell — “I’m going quiet”

Grey Market Premium (GMP): Strong Start for the IPO

As of November 20, the Sudeep Pharma IPO GMP stands at ₹130.With the upper price band at ₹593, the expected listing price is around ₹723, implying a premium of nearly 22%—a positive signal for investors looking for listing gains.

Key Details about the Sudeep Pharma IPO

The IPO Price Band for Sudeep Pharma has been set between ₹563 and ₹593 per share, giving investors a fair entry range. The IPO will open for subscription on Friday, November 21, and it will close on Tuesday, November 25.

The Fresh issue will be of 16 lakh shares (~₹95 crore), and there will be an Offer for sale (OFS) of 1,34,90,726 shares. A total of 50 per cent of the net issue has been reserved for qualified institutional buyers (QIBs), and 35 per cent of the net issue has been reserved for retail investors.

The remaining 15 per cent is reserved for non-institutional investors (NIIs).

Sudeep Pharma IPO lot size is 25 shares. The minimum application size for a retail investor is one lot. With the issue’s upper price band at ₹593, the minimum amount of investment required by retail investors is ₹14,825. The maximum lot size for retail investors is 13 for ₹1,92,725.

ICICI Securities and IIFL Capital Services Limited are the book-running lead managers of the issue. MUFG Intime India Private Limited is the registrar of the Sudeep Pharma IPO.

The allotment of shares is expected to be finalised on Wednesday, November 26. Successful bidders can get the shares on Thursday, November 27, and those who fail to get the allotment will get the refund on the same day. Sudeep Pharma IPO will list on the BSE and the NSE on Friday, November 28.

Object of Sudeep Pharma IPO

The company plans to utilise the net amount for capital expenditure in the procurement of machinery for its production line located at Nandesari Facility I. Moreover, some portion of it will be used for general business purposes.

Sudeep Pharma business overview

Sudeep Pharma is a manufacturer of excipients and speciality ingredients for the pharmaceutical, food and nutrition industries. It has a domestic and global presence in key regions such as the US, South America, Europe, the Middle East, Africa, and Asia-Pacific.

Sudeep Pharma’s financial performance

This is noteworthy that as per reports, both profit and revenue of the company have reflected its sustainable growth over the last few financial years.

Sudeep Pharma’s IPO is attracting significant interest due to its strong financial track record, industry relevance, and healthy grey market premium. Investors looking for opportunities in the speciality chemicals and pharma-support sectors may find this offering worth considering.

Disclaimer:

This article is for informational purposes only and should not be considered financial advice. IPO investments are subject to market risks. Always consult your financial advisor before making any investment decisions.